Psyadon Pharmaceuticals Overview

Life ScienceCompany

Where is Psyadon Pharmaceuticals headquartered?

Psyadon Pharmaceuticals is headquartered in Germantown, Maryland.

What sector is Psyadon Pharmaceuticals in?

Psyadon Pharmaceuticals is a life science company.

When was Psyadon Pharmaceuticals founded?

Psyadon Pharmaceuticals was founded in 2004.

Psyadon Pharmaceuticals, Inc.

20451 Seneca Meadows Parkway,
Germantown, Maryland 20876
United States,
( 301) 919-2020
www.psyadonrx.com

Psyadon Pharmaceuticals, Inc. is a developer, register and marketer of an ecopipam, a new chemical entity with orphan drug designation for the treatment of pediatric Tourette Syndrome (TS) in patients under 16 years of age.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.